According to Eterna Therapeutics's latest financial reports the company's current revenue (TTM) is $0.06 M. In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.06 M | |
2022 | N/A | |
2021 | N/A | |
2020 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Sanofi SNY | $50.35 B | 74,058,595.47% | ๐ซ๐ท France |
Baxter BAX | $14.94 B | 21,983,723.53% | ๐บ๐ธ USA |
Omeros Corporation OMER | N/A | N/A | ๐บ๐ธ USA |
Geron GERN | $0.23 M | 248.53% | ๐บ๐ธ USA |
Genetic Technologies GENE | $17.17 M | 25,154.76% | ๐ฆ๐บ Australia |
Teva Pharmaceutical Industries TEVA | $15.84 B | 23,302,841.18% | ๐ฎ๐ฑ Israel |
Bio-Techne TECH | $1.14 B | 1,683,722.06% | ๐บ๐ธ USA |